AAN 2017: Must-See Sessions
You won’t want to miss these new features and sessions at this year’s American Academy of Neurology Annual Meeting, April 22-28, in Boston, MA.
Interesting Neuro: New Drugs & TBI Recovery
March news includes tools to manage brain injury and predict recovery, new drug hits and misses, and an updated epilepsy classification system.
IBIA 2017: Repercussions of TBI
Research presented at IBIA 2017 looked at risk behavior in adolescents, return to work, and maladaptive emotion regulation following TBI.
Neuro News Roundup: Stroke Outcomes
Studies include stroke risk with epilepsy, genetic predisposition for ischemic stroke, and dysphagia screening in stroke patients.
ACC 2017: Late-Breaking Clinical Trials
Research includes safety of digoxin with atrial fibrillation, comparison of cerebral embolic protection devices, and cerebral microbleed triggers.
ACC 2017: CV Risk Factors
Research includes a possible link between Zika & CV issues, CV effects of cannabis use, and neurocognitive impairment with PCSK9 variants.
Interesting Neuro: Tumor Tx and Stroke Recovery
March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.
Neuro News Roundup: Parkinson or parkinsonian?
Studies also include stem cell transplantation for treatment-refractory MS and aspirin use for headache to lessen the need for rescue medication.
ACTRIMS 2017 Forum: MS Treatment Clinical Trials
Research examined no evidence of disease activity and no evidence of progression with ocrelizumab as well as long-term results with mitoxantrone.
Top 10 Neurology Apps
Ten general and disease-specific apps for neurologists include assessment scales, anatomical diagrams, and interactive clinical decision support.
By clicking Accept, you agree to become a member of the UBM Medica Community.